spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 1


Fig. 1. XMAN1 inhibits the activin/nodal pathway in the Xenopus embryo. (A) Whole-mount in situ hybridization for chordin (chd) at stage 10.5. MO, antisense morpholino oligonucleotides against XMAN1; 4mmMO, four-base-mismatched MO. XMAN1 mRNA (1 ng/embryo) or MO (75 ng/embryo) was injected into two dorsal blastomeres at the four-cell stage. Arrowheads indicate the dorsal lip. (B) Suppression of Xnr1-dependent mesodermal induction by XMAN1. RT-PCR of animal caps for chd and goosecoid (gsc), dorsal mesoderm markers and Xenopus brachyury (Xbra), a pan-mesodermal marker, at the equivalent of stage 10.5. Xnr1 mRNA (100 pg/embryo) and either mRNA for XMAN1 (2 ng/embryo), C-terminal (CT)-XMAN1 (500 pg/embryo, equivalent amount in mol to XMAN1) or CT-truncated ({Delta}CT)-XMAN1 (1500 pg/embryo, equivalent amount in mol to XMAN1) were injected. FGFR is the loading control. (C) Suppression of activin/nodal-dependent Xnr1 intron1-luciferase (Int1) activation by XMAN1 constructs. A control of GL3-luciferase or an Int1 construct (100 pg/embryo) was injected together with a Renilla luciferase plasmid (2 pg/embryo), Xnr1 mRNA (100 pg/embryo) and mRNA for XMAN1 (1 ng/embryo), CT (250 pg/embryo) or {Delta}CT (750 pg/embryo).





Right arrow Return to article